Stuart Cobb serves as Executive at Neurogene Inc., where they oversee executive responsibilities. Since joining the company, Stuart Cobb has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 20, 2026 involved receiving (via award) 16,500 shares valued at $0.
Stuart Cobb currently holds 37,294 shares of Neurogene Inc. (NGNE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Stuart Cobb has been a net neutral trader of NGNE stock. They have purchased $0 and sold $0 worth of shares.
Stuart Cobb's most recent insider trade was on Feb 20, 2026, when they sold 16,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |